The ACQUITY Premier Oligonucleotide BEH C18 Column, 300Å, 1.7 µm, 2.1 x 100 mm, is used to separate oligonucleotides via ion-pairing reversed-phase (IP-RP) chromatography on UPLC systems. Each column incorporates Waters' BEH hybrid particle technology for unmatched pH and temperature stability and our MaxPeak Premier high performance surface technology for ultra-low non-specific adsorption. Stationary phase batches are also QC tested using the Waters MassPREP Oligonucleotide Standard to ensure lot-to-lot performance. Premier Oligonucleotide BEH Columns provide unmatched sensitivity, exquisite reproducibility, and excellent out-of-the-box performance. Columns with 130 Å pore size particles deliver industry leading performance for short-mer oligonucleotide separations, and new 300Å pore size columns offer enhanced resolution for longer oligonucleotides.
|
Química |
C18 |
|
Modo de separação |
Fase reversa |
|
Substrato de partículas |
Hybrid |
|
pH Range Min |
1 pH |
|
pH Range Max |
12 pH |
|
Maximum Pressure |
18000 psi (1240 Bar) |
|
Endcapped |
Sim |
|
Silanol Activity |
Low |
|
Particle Shape |
Spherical |
|
Tamanho de partícula |
1.7 µm |
|
Endfitting Type |
Parker-style |
|
Tamanho de poro |
300 Å |
|
QC Tested |
Oligonucleotide |
|
Formato |
Coluna |
|
Sistema |
UPLC |
|
Tecnologia de partículas |
BEH |
|
Technique |
LC |
|
Classificação da USP |
L1 |
|
Diâmetro interno |
2.1 mm |
|
Comprimento |
100 mm |
|
Carbon Load |
18 % |
|
eCord |
Sim |
|
UNSPSC |
41115711 |
|
Aplicação |
Oligonucleotídeo, Gene Therapeutics |
|
Marca |
ACQUITY |
|
Tipo de produto |
Colunas |
|
Units per Package |
1 pk |